Englewood Lab, Inc. (KOSDAQ:950140)
10,300
-70 (-0.68%)
At close: May 16, 2025, 3:30 PM KST
Englewood Lab Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 161,612 | 182,220 | 206,784 | 151,509 | 160,816 | 137,168 | Upgrade
|
Other Revenue | -0 | - | - | -0 | - | - | Upgrade
|
Revenue | 161,612 | 182,220 | 206,784 | 151,509 | 160,816 | 137,168 | Upgrade
|
Revenue Growth (YoY) | -38.94% | -11.88% | 36.48% | -5.79% | 17.24% | 2.89% | Upgrade
|
Cost of Revenue | 135,371 | 143,781 | 159,130 | 125,804 | 126,615 | 112,355 | Upgrade
|
Gross Profit | 26,241 | 38,440 | 47,654 | 25,705 | 34,202 | 24,813 | Upgrade
|
Selling, General & Admin | 15,580 | 15,447 | 16,159 | 12,389 | 13,223 | 13,689 | Upgrade
|
Research & Development | 2,978 | 2,808 | 2,218 | 2,433 | 2,437 | 2,264 | Upgrade
|
Operating Expenses | 20,051 | 19,645 | 18,799 | 15,823 | 17,297 | 16,944 | Upgrade
|
Operating Income | 6,190 | 18,795 | 28,855 | 9,882 | 16,905 | 7,869 | Upgrade
|
Interest Expense | -1,088 | -906.85 | -698.93 | -977.36 | -741.1 | -976.24 | Upgrade
|
Interest & Investment Income | 667.21 | 599.38 | 218.05 | 12.11 | 7.76 | 1.95 | Upgrade
|
Currency Exchange Gain (Loss) | 4,641 | 7,229 | 42.38 | 545.21 | 1,028 | -787.96 | Upgrade
|
Other Non Operating Income (Expenses) | 24.21 | 17.6 | -19.2 | -234.14 | -32.29 | 11.4 | Upgrade
|
EBT Excluding Unusual Items | 10,434 | 25,734 | 28,397 | 9,227 | 17,167 | 6,118 | Upgrade
|
Gain (Loss) on Sale of Investments | -0.09 | - | - | - | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | -8.52 | 9.9 | 317.98 | -650.31 | -1,701 | -1,270 | Upgrade
|
Asset Writedown | - | - | - | -224.1 | -367.97 | -47.2 | Upgrade
|
Pretax Income | 10,425 | 25,744 | 28,715 | 8,353 | 15,098 | 4,801 | Upgrade
|
Income Tax Expense | 4,724 | 6,116 | 7,973 | 1,088 | 100.74 | 1,719 | Upgrade
|
Net Income | 5,702 | 19,628 | 20,742 | 7,265 | 14,997 | 3,082 | Upgrade
|
Net Income to Common | 5,702 | 19,628 | 20,742 | 7,265 | 14,997 | 3,082 | Upgrade
|
Net Income Growth | -92.36% | -5.37% | 185.50% | -51.55% | 386.63% | 35.85% | Upgrade
|
Shares Outstanding (Basic) | - | 20 | 20 | 20 | 20 | 20 | Upgrade
|
Shares Outstanding (Diluted) | - | 20 | 20 | 20 | 20 | 20 | Upgrade
|
EPS (Basic) | - | 987.92 | 1044.02 | 365.69 | 754.85 | 155.12 | Upgrade
|
EPS (Diluted) | - | 987.92 | 1044.02 | 365.69 | 754.85 | 155.12 | Upgrade
|
EPS Growth | - | -5.37% | 185.50% | -51.55% | 386.63% | 35.85% | Upgrade
|
Free Cash Flow | 16,576 | 8,549 | 18,060 | 5,462 | -9,232 | 3,321 | Upgrade
|
Free Cash Flow Per Share | - | 430.32 | 908.99 | 274.94 | -464.68 | 167.17 | Upgrade
|
Dividend Per Share | 100.000 | 100.000 | - | - | - | - | Upgrade
|
Gross Margin | 16.24% | 21.09% | 23.04% | 16.97% | 21.27% | 18.09% | Upgrade
|
Operating Margin | 3.83% | 10.32% | 13.95% | 6.52% | 10.51% | 5.74% | Upgrade
|
Profit Margin | 3.53% | 10.77% | 10.03% | 4.79% | 9.33% | 2.25% | Upgrade
|
Free Cash Flow Margin | 10.26% | 4.69% | 8.73% | 3.60% | -5.74% | 2.42% | Upgrade
|
EBITDA | 11,481 | 23,912 | 33,249 | 14,230 | 21,209 | 12,307 | Upgrade
|
EBITDA Margin | 7.10% | 13.12% | 16.08% | 9.39% | 13.19% | 8.97% | Upgrade
|
D&A For EBITDA | 5,291 | 5,116 | 4,394 | 4,349 | 4,304 | 4,438 | Upgrade
|
EBIT | 6,190 | 18,795 | 28,855 | 9,882 | 16,905 | 7,869 | Upgrade
|
EBIT Margin | 3.83% | 10.32% | 13.95% | 6.52% | 10.51% | 5.74% | Upgrade
|
Effective Tax Rate | 45.31% | 23.76% | 27.77% | 13.02% | 0.67% | 35.81% | Upgrade
|
Advertising Expenses | - | 175.48 | 116.46 | 54.36 | 12.05 | 10.6 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.